-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

113. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational: Poster II

Symposia: Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Keara Little, BSc1*, Zhenqi Zhu, PhD2*, Oluwabukola Gbotosho, PhD3 and Punam Malik, MD4

1Cancer and Blood Diseases Institute, Cincinnati Children's Hospital and Medical Center, Mount Orab, OH
2Cincinnati Children's Hospital and Medical Center, Cincinnati
3University of Cincinnati, Cincinnati, OH
4Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Marisa Morakis, BS1*, Luojie Huang, MS1*, Gregory N McKay, MD, PhD1*, Sophie Lanzkron, MD2,3, Lydia H. Pecker, MD, MS2 and Nicholas J Durr, PhD1*

1Biomedical Engineering, Johns Hopkins University, Baltimore, MD
2Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD
3Thomas Jefferson University, Philadelphia, PA

Ahmed Daak, MD, PhD, MSc, DPM/MFPM1, David R. Light, PhD2, Fuad Abdulla3*, Chunsheng Chen, PhD3*, Julia Nguyen, B.S.4*, Conglin Ruan, B.S.4*, Michael Storek5*, Dimitry Ofengeim6*, Alexandra Hicks6*, Michelle Lee5*, Vincent Mikol6*, Gregory M. Vercellotti, MD3 and John D. Belcher, PhD3

1Sanofi, Cambridge, MA
2Sanofi Consultant, San Mateo, CA
3Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN
4Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
5Immunology and Inflammation Research, Sanofi, Cambridge, MA
6Research & Development, Sanofi, Vitry-sur-Seine, France

Elisabeth Dovern, MD1*, Tim R. Mocking2,3*, Mette D. Hazenberg, MD, PhD4,5*, Cornelis R van der Torren, MD, PhD6, Boukje M. Beuger7*, Robin Van Bruggen, PhD7*, Simon Tol7*, Erik Mul8*, Marjolein van der Pot6*, Arjan A. van de Loosdrecht, MD, PhD3,9*, Myrddin Verheij, PhD2,10*, Karin Fijnvandraat, MD, PhD6*, Carlijn Voermans, PhD2,10*, Bart J. Biemond1, Costa Bachas, PhD2,3* and Erfan Nur, MD, PhD1,11

1Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, Netherlands
2Department of Hematology, Amsterdam UMC location Vrije Universiteit, Amsterdam, Netherlands
3Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, Netherlands
4Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands
5Sanquin Research, Amsterdam, Netherlands
6Department of Pediatric Hematology, Amsterdam UMC, Emma Children's Hospital, Amsterdam, Netherlands
7Department of Molecular Hematology, Sanquin Research and Landsteiner Laboratory, Amsterdam, Netherlands
8Department of Research Facilities, Sanquin Research and Landsteiner Laboratory, Amsterdam, Netherlands
9Department of Hematology, Amsterdam University Medical Center, Free University, Amsterdam, Netherlands
10Department of Hematopoiesis, Sanquin Research and Landsteiner Laboratory, Amsterdam, Netherlands
11Department of Blood Cell Research, Sanquin Research and Landsteiner Laboratory, Amsterdam, Netherlands

Guohui Ren, MD, PhD1*, Maria Armila Ruiz, MS2*, Suman Setty3*, Victor R. Gordeuk, MD4 and Santosh L. Saraf, MD5

1University of Illinois At Chicago, CHICAGO, IL
2University of Illinois At Chicago, Chicago, IL
3University of Illinois Chicago, Chicago, IL
4Department of Medicine, University of Illinois Hospital, Chicago, IL
5Department of Medicine, University of Illinois College of Medicine, Willowbrook, IL

Rudra Ray, PhD1*, Haiou Li2*, Nancy Asomaning, MS1*, Kang Le, PhD1*, Xunde Wang, PhD1*, Justin Lack3*, Yuesheng Li4*, Sayuri Kamimura, MS5*, Zenaide Quezado, MD5,6 and Swee Lay Thein, MBBS, DSc, FRCP, FRCPath, MRCP, MRCPath1

1Sickle Cell Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD
2Sickle Cell Branch, National Heart, Lung, and Blood Institute, NIH, Arlington, VA
3Bioinformatics (NCBR)/Integrated Data Sciences Section(IDSS)/ Research Technology Branch/DIR, NIAID, NIH, National Institutes of Health, Bethesda, MD
4DNA SEQUENCING & GENOMICS CORE, NHLBI, NIH, National Institutes of Health, Bethesda, MD
5Department of Perioperative Medicine, National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, MD
6Sickle Cell Branch, NHLBI, NIH, Bethesda, MD

Thiago Trovati Maciel, PhD1*, Nabiha Sbeih, MD1*, Rachel Rignault-Bricard1*, Isabelle Chevalme1*, Slimane Allali1,2*, Camille Brochier, PhD3*, Anna Kiialainen4*, Tovo David4 and Olivier Hermine, MD, PhD1,5

1Institut Imagine - INSERM U1163, Paris, France
2Sickle Cell Center, Pediatrics Department, Necker Hospital for Sick Children, APHP, Paris Cité University, Paris, FRA
3Institut Roche, Boulogne Billancourt, France
4F. Hoffmann-La Roche Ltd, Basel, Switzerland
5Hematology, Necker Hospital, Greater Paris University Hospitals (AP-HP), Paris, France

Christopher Chambliss, PhD1, Elizabeth Manci, MD2*, Elizabeth Eldeiry3*, Earl Fields Jr., MPH1*, Jesse Bueno1*, Satheesh Chonat, MD1 and David R Archer, PhD1

1Aflac Cancer and Blood Disorders Center, Emory University, Atlanta, GA
2Univ. of S. AL Children's & Women's Hosp., Mobile, AL
3Georgia Institute of Technology, Atlanta, GA

Gang Huang, PhD1,2, Jie Bai1*, Mingzhe Pan1*, Dong Liu, PhD3*, Min Xiong3* and Shaojiang Deng, PhD3*

1Department of Cell Systems and Anatomy, UT Health San Antonio, San Antonio, TX
2Department of Pathology and Laboratory Medicine, UT Health San Antonio, San Antonio, TX
3Kind Pharmaceuticals, LLC, Redwood City, CA

Lucas F.S. Gushiken, PhD1*, Sarah Liane Linguet, MD2*, Erica M.F. Gotardo, Ph.D.1*, Pamela L Brito, PhD1*, Flavia C. Leonardo, PhD1*, Laetitia Claer, MSc3*, Slim Azouzi, PhD2*, Caroline Le Van Kim, PhD2*, Fernando Ferreira Costa, MD, PhD1, Sandrine Laurance, PhD2*, Berengere Khoel, MD, PhD2* and Nicola Conran, PhD1

1Hematology and Transfusion Center, University of Campinas - UNICAMP, Campinas, Sao Paulo, Brazil
2Université Paris Cité and Université des Antilles, INSERM, Biologie intégrée du globule rouge, F-75015, Paris, France
3Université Paris Cité and Université des Antilles, INSERM, BIGR, F-75015 Paris, F97150 Pointe à Pitre, France, Paris, France

Kang Le, PhD1*, Zenaide Quezado, MD2, Haiou Li3*, Sayuri Kamimura, MS2*, Meghann L. Smith4*, Yuki Tahara5*, Yujeong Lee5*, Anna Conrey, NP1*, Josie Schultz6*, Thorkell Andresson, PhD7*, Eric T Kool5* and Swee Lay Thein, MBBS, DSc, FRCP, FRCPath, MRCP, MRCPath8

1Sickle Cell Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD
2Department of Perioperative Medicine, National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, MD
3Sickle Cell Branch, National Heart, Lung, and Blood Institute, NIH, Arlington, VA
4Clinical Center, National Institutes of Health, Bethesda, MD
5Department of Chemistry, Stanford University, Stanford, CA
6CCR Protein Characterization Laboratory, National Cancer Institute, NIH, Frederick, MD
7CCR Protein Characterization Laboratory, National Cancer Institute, National Institutes of Health, Frederick, MD
8Sickle Cell Branch, National Heart, Lung & Blood Institute, Bethesda, MD

Xunde Wang, PhD1*, Yechan Cho, BS1*, Nancy Asomaning, MS1*, Maureen Lundt, MS1*, Anna Conrey, NP1*, Britney Kruah, MS1*, Amber M Yates, MD2*, Megan Wind-Rotolo, PhD2, Haiou Li3*, Kang Le, PhD1* and Swee Lay Thein, MBBS, DSc, FRCP, FRCPath, MRCP, MRCPath4

1Sickle Cell Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD
2Agios Pharmaceuticals, Inc., Cambridge, MA
3Sickle Cell Branch, National Heart, Lung, and Blood Institute, NIH, Arlington, VA
4Sickle Cell Branch, National Heart, Lung & Blood Institute, Bethesda, MD

Justin J Yoo, MD1,2, Kennedy N Goldsborough, PhD3*, Britney Hernandez, BS3*, Ashwin P. Patel, MD, PhD, MPH4 and Vivien Sheehan, MD, PhD5

1Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Avondale Estates, GA
2Georgia Comprehensive Sickle Cell Center at Grady Health System, Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA
3Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA
4Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
5Emory University School of Medicine, Atlanta, GA

Rikesh K Dubey, PhD1, Omika Katoch, PhD1*, Nicholas Swendrowski, MS1* and Prithu Sundd, PhD1,2

1Thrombosis and Hemostasis Program, VERSITI Blood Research Institute, Milwaukee, WI
2Medical College of Wisconsin, Division of Hematology and Oncology, Milwaukee, WI

Daniel M Sop, MS, BS1, Yue May Zhang, PhD2* and Wally R Smith, MD2

1Sickle Cell Disease program / General Internal Medicine, Virginia Commonwealth University, Glen Allen, VA
2Virginia Commonwealth University, Richmond, VA

*signifies non-member of ASH